Dietary potassium and diuretic therapy.
作者信息
Bateson M C, Lant A F
出版信息
Lancet. 1973 Aug 18;2(7825):381-2. doi: 10.1016/s0140-6736(73)93228-5.
PMID:4124557
Abstract
摘要
相似文献
1
Dietary potassium and diuretic therapy.
Lancet. 1973 Aug 18;2(7825):381-2. doi: 10.1016/s0140-6736(73)93228-5.
2
[Potassium deficiency and diuretics].
Ned Tijdschr Geneeskd. 1973 Aug 18;117(33):1236-8.
3
[Drug information. Potassium problems during treatment with diuretics].
Ugeskr Laeger. 1976 Sep 6;138(37):2237-41.
4
[The need of potassium loss compensation in treatment with diuretics].[利尿剂治疗中钾丢失补偿的必要性]
Klin Med (Mosk). 1989 Jun;67(6):21-7.
5
Diuretic-induced potassium deficits: principles, opinions, and practical therapeutics.
Am J Med. 1984 Nov 5;77(5A):1-2.
6
[The role of potassium-sparing diuretics in the treatment of cardiac insufficiency].
G Clin Med. 1988 Jan;69(1):31-3, 36.
7
Potassium supplements and diuretics.
Lancet. 1972 Oct 21;2(7782):882. doi: 10.1016/s0140-6736(72)92254-4.
8
[Potassium-sparing diuretics (spironolactone, triamterene, amylorid)].保钾利尿剂（螺内酯、氨苯蝶啶、阿米洛利）
Orv Hetil. 1996 Sep 1;137(35):1907-14.
9
Total-body potassium in hypertension patients during prolonged diuretic therapy.长期利尿治疗期间高血压患者的全身钾含量
Lancet. 1972 Jul 1;2(7766):8-12. doi: 10.1016/s0140-6736(72)91275-5.
10
Potassium supplements or potassium-sparing agents.钾补充剂或保钾药物。
Acta Pharmacol Toxicol (Copenh). 1984;54 Suppl 1:107-13. doi: 10.1111/j.1600-0773.1984.tb03642.x.
Zotero 插件